Consumer Goods » Food, Beverages & Tobacco | Mera Pharmaceuticals Inc.

Mera Pharmaceuticals Inc. | Cash Flow

Fiscal year is November-October. All values USD Thousands.
2006
2007
2008
2009
2010
Net Income before Extraordinaries
508.40
322.30
1,945.40
192.90
537.80
Depreciation, Depletion & Amortization
230.70
213.50
220.90
84.60
28.00
Other Funds
17.10
81.20
1,696.70
20.40
314.40
Funds from Operations
260.60
27.50
27.70
87.80
195.40
Changes in Working Capital
58.00
16.80
90.90
61.40
348.20
Net Operating Cash Flow
-
-
118.60
26.50
152.80
Capital Expenditures
-
-
-
24.10
150.00
Purchase/Sale of Investments
-
-
34.40
34.40
-
Net Investing Cash Flow
-
-
34.40
10.30
150.00
Issuance/Reduction of Debt, Net
-
-
13.40
-
-
Net Financing Cash Flow
-
-
159.60
-
-
Net Change in Cash
7.50
6.10
6.60
16.20
2.80
Free Cash Flow
-
-
118.60
50.60
2.80
Change in Capital Stock
-
-
173.00
-
-
Miscellaneous Funds
-
-
0.00
0.00
0.00

About Mera Pharmaceuticals

View Profile
Address
73-4460 Queen Ka'Ahumanu Highway
Kailua-Kona Hawaii 96740
United States
Employees -
Website http://www.merapharma.com
Updated 07/08/2019
Mera Pharmaceuticals, Inc. is a marine biotechnology company, which engages in the provision of photobioreactor technology and owns extensive intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. It also manufactures natural astaxanthin from haematococcus pluvialis microalgae. The company was founded in June 2002 and is headquartered in Boca Raton, Fl.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.